12:00 AM
Apr 22, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Immunomedics preclinical data

In a mouse model of lymphoma, 5 doses of 43 µg IV (19)-3s led to a survival rate of 75% compared to 0% for mice treated...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >